These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3770163)

  • 41. [Prevention of postresuscitation heart failure by using ionol].
    Meerson FZ; Dolgikh VT
    Biull Eksp Biol Med; 1983 Apr; 95(4):13-6. PubMed ID: 6831009
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Peribronchial lymphotropic therapy in the combined treatment of patients with progressive pulmonary tuberculosis].
    Pletnev GV; Krasnov DV
    Probl Tuberk Bolezn Legk; 2003; (12):3-5. PubMed ID: 15004961
    [No Abstract]   [Full Text] [Related]  

  • 43. [The use of antioxidants in the complex therapy of patients with infiltrating pulmonary tuberculosis].
    Starostenko EV; Dolzhanskiĭ BM; Salpagarov AM; Levchenko TN
    Probl Tuberk; 1991; (1):9-11. PubMed ID: 1903529
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Pathogenetic therapy of pulmonary tuberculosis in adolescents].
    Pavlova MV
    Probl Tuberk; 1994; (3):19-21. PubMed ID: 7937663
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Protein isolate from the herb, Phyllanthus niruri L. (Euphorbiaceae), plays hepatoprotective role against carbon tetrachloride induced liver damage via its antioxidant properties.
    Bhattacharjee R; Sil PC
    Food Chem Toxicol; 2007 May; 45(5):817-26. PubMed ID: 17175085
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Effectiveness of alpha-tocopherol in eliminating and preventing the hepatotoxic action of tuberculostatics].
    Grechin SA; Suslov EI; Mel'nik VP; Shuripa VP; Protsiuk RG
    Vrach Delo; 1987 Mar; (3):60-2. PubMed ID: 3590706
    [No Abstract]   [Full Text] [Related]  

  • 47. [Effectiveness of chlorprothixene in the combined treatment of pulmonary tuberculosis patients].
    Gunich LA; Vishnevskiĭ BI; Volkon VM
    Probl Tuberk; 1986; (8):35-9. PubMed ID: 3774792
    [No Abstract]   [Full Text] [Related]  

  • 48. [Effectiveness of tuberculin in the combined treatment of pulmonary tuberculosis patients].
    Burukhina LV; Petrova GN
    Probl Tuberk; 1985; (8):31-3. PubMed ID: 4059205
    [No Abstract]   [Full Text] [Related]  

  • 49. [Lipid peroxidation in the development of epileptic activity].
    Nikushkin EV
    Patol Fiziol Eksp Ter; 1987; (6):19-24. PubMed ID: 3127799
    [No Abstract]   [Full Text] [Related]  

  • 50. [Study of hepatic function of patients with pulmonary tuberculosis treated with morphazinamide].
    Stupenengo RH; Martínez M
    Prensa Med Argent; 1966 Aug; 53(33):1808-11. PubMed ID: 5994109
    [No Abstract]   [Full Text] [Related]  

  • 51. Longitudinal study of oxidative status in 312 cystic fibrosis patients in stable state and during bronchial exacerbation.
    Lagrange-Puget M; Durieu I; Ecochard R; Abbas-Chorfa F; Drai J; Steghens JP; Pacheco Y; Vital-Durand D; Bellon G
    Pediatr Pulmonol; 2004 Jul; 38(1):43-9. PubMed ID: 15170872
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Chemotherapy-induced lung functional changes in patients with destructive pulmonary tuberculosis].
    Nefedov VB; Smirnova DG
    Probl Tuberk; 1996; (6):60-3. PubMed ID: 9019776
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Use of essentiale in chronic liver diseases in patients with pulmonary tuberculosis].
    Blikhar EM; Skakun NP
    Probl Tuberk; 1988; (3):41-4. PubMed ID: 3387393
    [No Abstract]   [Full Text] [Related]  

  • 54. Tuberculosis: 9. Treatment.
    Hershfield E
    CMAJ; 1999 Aug; 161(4):405-11. PubMed ID: 10478167
    [No Abstract]   [Full Text] [Related]  

  • 55. [The clinical use of the new antioxidant thiotriazoline in ischemic ophthalmopathies].
    Mazur IA; Maksimenko SF; Belenichev IF; Taranenko DA; Deriapa IV; Zavgorodniaia NG
    Eksp Klin Farmakol; 1995; 58(3):59-62. PubMed ID: 7663303
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Lipid peroxidation and activity of antioxidant enzymes in thyroidectomized rats].
    Hrinevych IuIa; Bendiuh HD; Bilokin' IuM; Trembach OM
    Fiziol Zh (1994); 2004; 50(6):83-7. PubMed ID: 15732763
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Clinico-biomedical characteristics in manifestations of drug intolerance in patients with pulmonary tuberculosis].
    Sergeev IS; Ignatova AV
    Sov Med; 1973 Jul; 36(7):35-9. PubMed ID: 4776705
    [No Abstract]   [Full Text] [Related]  

  • 58. [Free-radical lipid oxidation and the antioxidant system in the pathogenesis of gastroduodenal ulcerations (a review of the literature)].
    Zvershkhanovskiĭ FA; Vaĭnshteĭn SG
    Vrach Delo; 1987 Sep; (9):42-7. PubMed ID: 3321704
    [No Abstract]   [Full Text] [Related]  

  • 59. [Antioxidants in the combined therapy of diabetic angiopathies].
    Bobyreva LE
    Eksp Klin Farmakol; 1998; 61(1):74-80. PubMed ID: 9575419
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lipid peroxidation in autoimmune systemic vasculitides. Effect of corticoid treatment on lipid peroxidation. Antioxidant protection with vitamin E.
    Serban MG; Tănăseanu S
    Rom J Intern Med; 1994; 32(2):137-42. PubMed ID: 7920328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.